I was a neurology physician before setting up Sihuan Pharmaceutical. While tending to patients in that capacity I witnessed what serious damage cardio-cerebral vascular diseases can cause to people's health. That experience has inspired me to embark on a journey in search of drugs that can help relieving pain for patients suffering from such diseases. Guided by that vision, Sihuan Pharmaceutical has been committed to the development and marketing of pioneering cardio-cerebral vascular drugs ever since in our quest to improve the well-being of our customers.

Founded in 2001, Sihuan Pharmaceutical has been able to successfully capitalize on the growth opportunities in the past decade despite all the challenges along the way. Through making full use of the value chain and continually strengthening our core competencies we have been able to stand out in a highly competitive market. Today, we are recognized as a respected leader in the pharmaceutical industry in China. To position ourselves for future opportunities offered by the country's fast-growing pharmaceutical market, we remain firmly focused on the research and development of cardio-cerebral vascular drugs and their promotion. Our goal is to continue to consolidate our leadership in the cardio-cerebral vascular drug franchise in China and to further enrich our product portfolio by adding products with high growth potential. To achieve this, we will continue to expand our sales and distribution network and production capacity so that we can better capture opportunities offered by China's ever-growing demand for quality pharmaceutical products.

I would like to express my sincere gratitude to our industry peers who have been supportive of our work. Sihuan Pharmaceutical will continue to embrace its values of cooperation and sharing, and move forward with our friends and partners in our common endeavor to ensure the long-term and robust development of the industry.